Page 14 - Celularity Inc News Today

Zapolin Set to Outline the Lucrative Financial Potential of Psychedelic Medicine

GAITHERSBURG, Md., March 22, 2022 /PRNewswire/ -- MaxCyte, Inc., (NASDAQ: MXCT) (LSE: MXCT) is a leading commercial cell-engineering company focused on providing enabling platform technologies

Redbox Entertainment Inc currently trades at $1.88.

Combined company expected to have a pro forma equity value post-money of approximately $1.64 billion, subject to potential adjustment, and with up to $140...

Celularity Inc (NASDAQ:CELU – Get Rating)’s stock price traded down 13.7% during trading on Monday . The company traded as low as $7.60 and last traded at $7.77. 8,943 shares traded hands during mid-day trading, a decline of 96% from the average session volume of 206,427 shares. The stock had previously closed at $9.00. A […]

Celularity Inc (NASDAQ:CELU – Get Rating) was the target of some unusual options trading on Wednesday. Investors purchased 1,734 call options on the stock. This represents an increase of approximately 502% compared to the typical volume of 288 call options. Several hedge funds and other institutional investors have recently modified their holdings of the company. […]

Orlando, Fla. (PRWEB) February 22, 2022 -- The annual Lake Nona Impact Forum will convene 300 of the brightest minds and global thought leaders in health,

/PRNewswire/ -- Tony Robbins, the author of six internationally bestselling books, announces the release of LIFE FORCE, his latest guidebook to living a...

Fourth quarter 2021 revenue expected to be greater than $10 million Full year 2021 revenue expected to be greater than $33.7 millionInstalled base of...

24.01.2022 - Fourth quarter 2021 revenue expected to be greater than $10 million Full year 2021 revenue expected to be greater than $33.7 millionInstalled base of greater than 500 instruments 15 SPLs, covering more than 95 programs, of which over 15% have ... Seite 1